Tag Archives: Section 101

Roche Molecular Systems, Inc. v. Cepheid – Are Primers “Natural Products”?

Anyone familiar with the fate of claims to primers used in PCR, to amplify a stretch of target DNA in order to determine whether or not a significant mutation is present, could write the opinion in this appeal (No. 2017-1690 … Continue reading

Posted in Section 101 | Tagged , , , , , , , , , , | 1 Comment

Ex Parte Schwartz – A Pyrrhic Reversal of a 101 Rejection

The PTAB decision reversing the Examiner’s s. 101 rejection in Ex Parte Schwartz, Appeal 2017-004975 (August 2, 2018) both demonstrates the need for more Examiner training on the ever-changing definition/identification of an abstract idea, particularly in the context of inventions … Continue reading

Posted in Section 101 | Tagged , , , , , , | Leave a comment

Chisum Patent Academy

The Federal Circuit and Supreme Court Have Already Issued 100 Precedential Patent Opinions in 2017! Are You Up to Speed? Stay on top of the latest critical developments by joining us this spring in Houston or Cincinnati. The Chisum Patent … Continue reading

Posted in CLE, Conferences and Classes | Tagged , , , , , , , | Leave a comment

USPTO Myriad-Mayo Guidance Still Not At An Alpha Standard

This is a guest post from Paul Cole. As readers will be aware, the USPTO published revised Guidance on Section 101 eligibility in December 2014 together with Nature-Based Examples and Abstract ideas examples. These materials and the case-law on which … Continue reading

Posted in Section 101 | Tagged , , , , , , , , , | Leave a comment